Vicare Pharmaceutical Technology Co., Ltd. is based on the research and development of innovative drugs, the transfer of generic drug technology, and the production and sales of pharmaceutical intermediates. The company has a complete R&D, production and sales system, has well-equipped synthesis, preparation and drug analysis laboratories, and has established industrialization partnerships with many manufacturers, laying a good foundation for the industrialization and marketization of the Waycare project. Foundation. Recently Waycare completed more than 200 million yuan in round B financing. This round of financing was led by Changjiang Venture Capital, jointly invested by Hongcheng Investment and Huadian Investment, and continued to be supported by Changjiang Industrial Investment and SDIC China Merchants. The raised funds will be used to accelerate the clinical development of the company’s core innovative drug products and the construction of the CDMO industrialization base.
This article is transferred from: https://www.itjuzi.com/investevent/13740066
This site is only for collection, and the copyright belongs to the original author.